45
Participants
Start Date
February 28, 2005
Primary Completion Date
May 31, 2015
Study Completion Date
May 31, 2015
Vignette, questionnaires and Saliva Samples
The short vignette discusses the health implications of potential molecular markers of cancer risk assessment. The questionnaire asks several multiple-choice questions to assess the participant's interest in and understanding of molecular risk assessment. Patients are instructed to swish with 10cc of Scope mouthwash and to expectorate into a sterile 50cc conical tube.
Urine Collection, Smoking cessation treatment
Single void urine specimens (approximately 50 ml) will be collected in pre-labeled specimen containers on a 3-monthly (±1 month) basis for 12 months. Standard evidence-based therapy for smoking cessation, including behavioral therapy and pharmacological therapy, is provided.
Memorial Sloan Kettering Cancer Center, New York
Weill Medical College of Cornell University
OTHER
Vanderbilt University School of Medicine
OTHER
Memorial Sloan Kettering Cancer Center
OTHER